Seymour H. Fein
Chief Tech/Sci/R&D Officer presso ONCOTELIC THERAPEUTICS, INC.
Profilo
Seymour H.
Fein is the founder of Serenity Pharmaceuticals Corp.
(founded in 2007) where he holds the title of Chief Medical Officer & Principal.
He is currently the Chief Medical & Regulatory Officer at Oncotelic Therapeutics, Inc. (since 2022) and the Chief Medical Officer at Ventria Bioscience, Inc. (since 2015).
In his former positions, he served as a Medical Director at Bayer Pharmaceuticals Corp., Bayer HealthCare Pharmaceuticals, Inc., Ohmeda PPD, Inc., Rorer Group, Inc., and Ohmeda, Inc. He was also a Director-Clinical Research & Development at Ohmeda PPD, Inc. Additionally, he held the position of Independent Director at Prospect Park Capital Corp.
from 2016 to 2020.
Dr. Fein was the Chief Medical Officer at Oncotelic Therapeutics, Inc. and Delcath Systems, Inc. from 2006 to 2008.
He also worked as a Senior Research Physician at Hoffmann-La Roche, Inc. and as a Principal at the US Food & Drug Administration.
Dr. Fein obtained his undergraduate degree from the University of Pennsylvania and his doctorate from New York Medical College.
Posizioni attive di Seymour H. Fein
| Società | Posizione | Inizio |
|---|---|---|
| ONCOTELIC THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 28/02/2023 |
Ventria Bioscience, Inc.
 Ventria Bioscience, Inc. BiotechnologyHealth Technology Ventria Bioscience, Inc. operates as a biopharmaceutical company. It offers Express Tec., a plant based recombinant protein supplement. The firm also offers controlling zoonotic disease and also provides access to its platform technology through contract manufacturing services. The company was founded by Raymond L. Rodriguez, Peter Matlock and William J. Rutter in 1993 and is headquartered in Fort Collins, CO. | Chief Tech/Sci/R&D Officer | 11/05/2015 |
Serenity Pharmaceuticals Corp.
 Serenity Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Serenity Pharmaceuticals Corp. develops products pharmaceuticals that address urinary conditions. The company was founded by Samuel Herschkowitz in 2007 and is headquartered in Milford, PA. | Founder | 01/01/2007 |
Precedenti posizioni note di Seymour H. Fein
| Società | Posizione | Fine |
|---|---|---|
| PROSPECT PARK CAPITAL CORP. | Director/Board Member | 23/01/2020 |
| DELCATH SYSTEMS, INC. | Chief Tech/Sci/R&D Officer | 17/07/2008 |
| ONCOTELIC THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
| ADHERA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
| Bayer Pharmaceuticals Corp. | Chief Tech/Sci/R&D Officer | - |
Formazione di Seymour H. Fein
| University of Pennsylvania | Undergraduate Degree |
| New York Medical College | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| ONCOTELIC THERAPEUTICS, INC. | Health Technology |
| DELCATH SYSTEMS, INC. | Health Technology |
| PROSPECT PARK CAPITAL CORP. | Finance |
| ADHERA THERAPEUTICS, INC. | Health Technology |
| Aziende private | 9 |
|---|---|
| Bayer Pharmaceuticals Corp. | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | Government |
Ventria Bioscience, Inc.
Ventria Bioscience, Inc. BiotechnologyHealth Technology Ventria Bioscience, Inc. operates as a biopharmaceutical company. It offers Express Tec., a plant based recombinant protein supplement. The firm also offers controlling zoonotic disease and also provides access to its platform technology through contract manufacturing services. The company was founded by Raymond L. Rodriguez, Peter Matlock and William J. Rutter in 1993 and is headquartered in Fort Collins, CO. | Health Technology |
Bayer HealthCare Pharmaceuticals, Inc.
 Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Bayer HealthCare Pharmaceuticals, Inc. manufactures pharmaceutical drugs. It offers pharmaceuticals and therapeutics in the areas of diagnostic imaging, hematology and cardiology, cancer, women's health and several other chronic diseases such as multiple sclerosis and Parkinson's disease. Bayer HealthCare Pharmaceuticals was founded in 1979 and is located in Wayne, NJ. | Health Technology |
| Ohmeda PPD, Inc. | |
Rorer Group, Inc.
 Rorer Group, Inc. Pharmaceuticals: MajorHealth Technology Rorer Group, Inc. developed pharmaceutical preparations. It also manufactured and supplied medical devices. The company was headquartered in Fort Washington, PA. | Health Technology |
Serenity Pharmaceuticals Corp.
Serenity Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Serenity Pharmaceuticals Corp. develops products pharmaceuticals that address urinary conditions. The company was founded by Samuel Herschkowitz in 2007 and is headquartered in Milford, PA. | Health Technology |
| Ohmeda, Inc. |
- Borsa valori
- Insiders
- Seymour H. Fein
